241 related articles for article (PubMed ID: 6755227)
1. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
Lucas PA; Woodhead JS; Brown RC
Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 metabolites in hypercalcaemic adults after kidney transplantation.
Lucas PA; Brown RC; Bloodworth L; Woodhead JS
Proc Eur Dial Transplant Assoc; 1983; 20():213-9. PubMed ID: 6318219
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
6. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
Chesney RW; Hamstra A; Rose P; DeLuca HF
Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
[TBL] [Abstract][Full Text] [Related]
8. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
Friedlander MA; Horst RL; Hawker CD
Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
[TBL] [Abstract][Full Text] [Related]
9. Plasma 1,25(OH)2D3 and iPTH in transplanted adults with persisting hypophosphataemia.
Ulmann A; Chkoff N; Garabedian M; Lacour B; Descamps JM; Kreis H; Crosnier J; Funck-Brentano JL
Proc Eur Dial Transplant Assoc; 1980; 17():467-72. PubMed ID: 7017692
[TBL] [Abstract][Full Text] [Related]
10. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction.
Lucas PA; Brown RC; Woodhead JS; Coles GA
Clin Nephrol; 1986 Jan; 25(1):7-10. PubMed ID: 3754187
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
Chesney RW; Hamstra AJ; Phelps M; DeLuca HF
Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
[TBL] [Abstract][Full Text] [Related]
13. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
[TBL] [Abstract][Full Text] [Related]
14. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
[TBL] [Abstract][Full Text] [Related]
15. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
Bulla M; Delling G; Offermann G; Ziegler R; Benz G; Lühmann H; Sanchez de Reutter A; Severin M
Proc Eur Dial Transplant Assoc; 1979; 16():644-8. PubMed ID: 232917
[TBL] [Abstract][Full Text] [Related]
16. Acute responses of parathyroid hormone and 1,25 dihydroxyvitamin D3 to unilateral nephrectomy in healthy donors.
Lucas PA; Brown RC; Woodhead JS
Nephrol Dial Transplant; 1986; 1(3):199-203. PubMed ID: 3110674
[TBL] [Abstract][Full Text] [Related]
17. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
18. Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis.
Youssef DM; Elshal AS; Abo Elazem AA
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):267-73. PubMed ID: 22382217
[TBL] [Abstract][Full Text] [Related]
19. Direct feed-back regulation of PTH-secretion by 1,25-dihydroxyvitamin D3 in renal failure: a controlled trial.
Madsen S; Olgaard K; Ladefoged J
Proc Eur Dial Transplant Assoc; 1980; 17():557-62. PubMed ID: 6894641
[TBL] [Abstract][Full Text] [Related]
20. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
Loras B; Parchoux B; Durr F
Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
